Matecznik & Centrum Probiotics Polska sp. z o.o.sp. k.
Manufacture of basic pharmaceutical products
Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2022 – the filing deadline has passed. 1 of 2 financial statements was filed late (for 2020, 256 days late).
- 2022not filed
- 202128/06/2022
- 202028/06/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2021.
Results vs industry
Industry
Trademarks
Matecznik & Centrum Probiotics Polska sp. z o.o. holds 2 active trademarks registered with the Polish Patent Office. 12 marks have expired or were not registered. The first mark was filed in 2016.
| Mark | Protected until | |
|---|---|---|
| ProBio ASekuracja | Jul 17, 2027 | |
| Witalny ogród | Jul 6, 2027 | |
| EmFarma Plus | – | |
| Ema5 z wrotyczem | – | |
| Ema5 | – |
Partners
| Partners | Partner role |
|---|---|
| General partner | |
Magdalena Górskaage 46 | General partner |
Elżbieta Teresa Gackaage 69 | Limited partner |
Dorota Kolbuszage 66 | General partner |
Manner of representation
The company is represented by each general partner independently. The sole general partner authorised to represent the company is Centrum Probiotics Polska sp. z o.o. The following method of representation applies at Centrum Probiotics Polska sp. z o.o.: two members of the management board acting jointly, or a member of the management board jointly with a commercial proxy, are authorised to make declarations of will and sign documents on behalf of the company. The persons representing Centrum Probiotics Polska sp. z o.o. – members of the management board: Jan Kolbusz – President of the Management Board; Bogusław Górski – Vice-President of the Management Board (whereas a commercial proxy, Jakub Skrzyński, has also been appointed at Centrum Probiotics Polska sp. z o.o.). A limited partner may represent the company exclusively as an attorney-in-fact or commercial proxy, or as a member of the management board of the general partner in accordance with the rules of representation specified in the articles of association of Centrum Probiotics Polska sp. z o.o.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2015-11-25 to 2024-03-11.
Reason for removal: Art. 96 ust. 9 pkt 4 (taxpayer or their representative fails to appear on summons of tax authorities)
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Nov 20, 2024 | Dissolution without liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
FAQ
Last updated: 2026-03-26